Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest MedImmune Stories

2013-12-19 08:27:36

ROCKVILLE, Md. and BALTIMORE, Dec. 19, 2013 /PRNewswire/ -- BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today that Reg Seeto, M.D., has been appointed to the BHI Board of Directors. Dr. Seeto currently serves as Vice President, Head of Partnering & Strategy at MedImmune, the global biologics research and...

2013-12-17 04:20:56

COPENHAGEN, Denmark; SEATTLE; STRASBOURG, France; and SAN FRANCISCO, Dec. 17, 2013 /PRNewswire/ -- CMC Biologics and OncoSynergy announced today that the two companies entered into an agreement for cell-line development, process development, analytical development and manufacturing of non-GMP material to enable early toxicology testing and cGMP material for IND enabling toxicology studies and Phase I clinical trials. This work will advance OncoSynergy's OS2966 monoclonal antibody...

2013-12-04 12:27:21

HARRISBURG, Pa., Dec. 4, 2013 /PRNewswire-USNewswire/ -- The Pennsylvania Department of Health and public and private partners will be offering free flu clinics throughout Pennsylvania during National Influenza Vaccination Week, Dec. 8-14, a week dedicated to advising people that it isn't too late to get the flu vaccine. "As families prepare to get together for the holidays, it's a perfect time to remind people of the importance of getting vaccinated," Secretary of Health Michael...

2013-11-22 23:33:27

Easy Protection from Flu Virus Now Available to Houston Residents Houston, TX (PRWEB) November 22, 2013 With flu season almost here, many residents across the Houston area are starting to think about calling their healthcare provider to schedule an appointment for their flu vaccination. However, some may be putting off making their appointment because they have a fear of needles or because they have an aversion or allergy to preservatives found in common vaccinations. The good news is...

2013-11-18 23:19:07

Reportbuyer.com just published a new market research report: China Human Vaccine Industry Report, 2012-2015. London (PRWEB) November 18, 2013 In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the lot release quantity of roughly 773 million person-portions. Restricted by China's national conditions and policies, EPI vaccines still...

2013-11-13 12:23:10

New, Educational Resource Provides Busy Parents with Tips to Help Keep Families Flu-Free as the 2013-2014 Flu Season Picks Up GAITHERSBURG, Md., Nov. 13, 2013 /PRNewswire/ -- Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced its partnership with Elizabeth Pantley, author of the best-selling No-Cry Solution parenting book series, to publish "A Parent's Guide to Flu Season." This guide aims to educate parents on the importance of flu...

2013-11-06 23:32:03

A study published in the October 28, 2013 Pediatrics Journal entitled, “Influenza-Associated Pediatric Deaths in the United States, 2004–2012” found 11% of the deaths were made up of infants under 6 months considered too young for flu shots. Photo-oxidation protection provided by UV-Aid kills bacteria and viruses helping to prevent colds, flu, and infections. Fort Myers, FL (PRWEB) November 05, 2013 A nearly decade long study documenting flu related fatalities in adolescents aged 18...

2013-11-05 23:18:43

A study published in the October 28, 2013 Pediatrics Journal entitled, “Influenza-Associated Pediatric Deaths in the United States, 2004–2012” found 11% of the deaths were made up of infants under 6 months considered too young for flu shots. Photo-oxidation protection provided by UV-Aid kills bacteria and viruses helping to prevent colds, flu, and infections. Fort Myers, FL (PRWEB) November 05, 2013 A nearly decade long study documenting flu related fatalities in adolescents aged 18...

2013-11-01 08:28:02

Company chosen to be a MAIN/Stage presenter on November 6 CHAPEL HILL, N.C., Nov. 1, 2013 /PRNewswire/ -- G1 Therapeutics, Inc. today announced that it has been selected as a MAIN/Stage presenter at the 2013 Southeast BIO Investor & Partnering Forum to be held November 6-7 at the Jefferson Hotel in Richmond, Virginia. Christy Shaffer, Ph.D., Executive Chair of G1's Board of Directors, will present to the audience of potential investors and partners on the afternoon of November 6....

2013-10-29 11:52:10

Scientists from the Center for Innovations in Medicine in the Biodesign Institute at Arizona State University have developed a comprehensive, microchip-based technology, called immunosignature diagnosis, which can rapidly and comprehensively measure an individual’s vaccine response, promising to take much of the initial guesswork out of predicting effective vaccines. Professor Stephen Albert Johnston and Joseph Barten Legutki, used a mouse model of influenza infection to determine how...